GDS Holdings Ltd
F:G401
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
GDS Holdings Ltd
F:G401
|
CN |
|
DiaMedica Therapeutics Inc
NASDAQ:DMAC
|
US |
|
Autodesk Inc
NASDAQ:ADSK
|
US |
|
B
|
Badger Meter Inc
F:33B
|
US |
|
C
|
Capital Bancorp Inc
F:316
|
US |
|
SMCP SA
F:SFC
|
FR |
|
W
|
WEG SA
F:B7F0
|
BR |
|
Dar Global PLC
F:L16
|
UK |
|
Z
|
Zimmer Biomet Holdings Inc
DUS:ZIM
|
US |
|
Dynavax Technologies Corp
LSE:0IDA
|
US |
Wall St Price Targets
G401 Price Targets Summary
GDS Holdings Ltd
According to Wall Street analysts, the average 1-year price target for G401 is 4.46 EUR with a low forecast of 3.46 EUR and a high forecast of 5.89 EUR.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is G401's stock price target?
Price Target
4.46
EUR
According to Wall Street analysts, the average 1-year price target for G401 is 4.46 EUR with a low forecast of 3.46 EUR and a high forecast of 5.89 EUR.
What is the Revenue forecast for GDS Holdings Ltd?
Projected CAGR
11%
Over the last 8 years, the compound annual growth rate for Revenue has been 28%. The projected CAGR for the next 8 years is 11%.
What is the Operating Income forecast for GDS Holdings Ltd?
Projected CAGR
27%
Over the last 8 years, the compound annual growth rate for Operating Income has been 44%. The projected CAGR for the next 8 years is 27%.
What is the Net Income forecast for GDS Holdings Ltd?
Projected CAGR
-6%
The compound annual growth rate for Net Income over the next 3 years is -6%.
